Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
OTCBB:KDUS's Cash to Debt is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. OTCBB:KDUS: No Debt )
OTCBB:KDUS' s 10-Year Cash to Debt Range
Min: 184.5   Max: No Debt
Current: No Debt

Interest Coverage No Debt
OTCBB:KDUS's Interest Coverage is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. OTCBB:KDUS: No Debt )
OTCBB:KDUS' s 10-Year Interest Coverage Range
Min: 9999.99   Max: 9999.99
Current: No Debt

F-Score: 2
Z-Score: 199.53
M-Score: -5.35
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
ROE (%) -3.07
OTCBB:KDUS's ROE (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. OTCBB:KDUS: -3.07 )
OTCBB:KDUS' s 10-Year ROE (%) Range
Min: -105.12   Max: 108.95
Current: -3.07

-105.12
108.95
ROA (%) -3.06
OTCBB:KDUS's ROA (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. OTCBB:KDUS: -3.06 )
OTCBB:KDUS' s 10-Year ROA (%) Range
Min: -75.33   Max: 68.89
Current: -3.06

-75.33
68.89
ROC (Joel Greenblatt) (%) -12.50
OTCBB:KDUS's ROC (Joel Greenblatt) (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. OTCBB:KDUS: -12.50 )
OTCBB:KDUS' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -70800   Max: -433.54
Current: -12.5

-70800
-433.54
Revenue Growth (%) -100.00
OTCBB:KDUS's Revenue Growth (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. OTCBB:KDUS: -100.00 )
OTCBB:KDUS' s 10-Year Revenue Growth (%) Range
Min: -100   Max: 0
Current: -100

-100
0
EBITDA Growth (%) 14.50
OTCBB:KDUS's EBITDA Growth (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. OTCBB:KDUS: 14.50 )
OTCBB:KDUS' s 10-Year EBITDA Growth (%) Range
Min: -76.2   Max: 48.7
Current: 14.5

-76.2
48.7
EPS Growth (%) 10.10
OTCBB:KDUS's EPS Growth (%) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. OTCBB:KDUS: 10.10 )
OTCBB:KDUS' s 10-Year EPS Growth (%) Range
Min: 0   Max: 51.8
Current: 10.1

0
51.8
» OTCBB:KDUS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with OTCBB:KDUS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 0.90
KDUS's P/B is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. KDUS: 0.90 )
KDUS' s 10-Year P/B Range
Min: 0.61   Max: 0.99
Current: 0.9

0.61
0.99
EV-to-EBIT -22.32
KDUS's EV-to-EBIT is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. KDUS: -22.32 )
KDUS' s 10-Year EV-to-EBIT Range
Min: 0   Max: 0
Current: -22.32

Current Ratio 363.22
KDUS's Current Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. KDUS: 363.22 )
KDUS' s 10-Year Current Ratio Range
Min: 4.19   Max: 24108
Current: 363.22

4.19
24108
Quick Ratio 363.22
KDUS's Quick Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. KDUS: 363.22 )
KDUS' s 10-Year Quick Ratio Range
Min: 4.19   Max: 24108
Current: 363.22

4.19
24108

Valuation & Return

vs
industry
vs
history
Price/Net Cash 1.84
KDUS's Price/Net Cash is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. KDUS: 1.84 )
KDUS' s 10-Year Price/Net Cash Range
Min: 0.39   Max: 4.67
Current: 1.84

0.39
4.67
Price/Net Current Asset Value 1.84
KDUS's Price/Net Current Asset Value is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. KDUS: 1.84 )
KDUS' s 10-Year Price/Net Current Asset Value Range
Min: 0.39   Max: 4.67
Current: 1.84

0.39
4.67
Price/Tangible Book 0.91
KDUS's Price/Tangible Book is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. KDUS: 0.91 )
KDUS' s 10-Year Price/Tangible Book Range
Min: 0.33   Max: 4
Current: 0.91

0.33
4
Forward Rate of Return (Yacktman) 4.27
KDUS's Forward Rate of Return (Yacktman) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. KDUS: 4.27 )
KDUS' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -27.7   Max: -23.7
Current: 4.27

-27.7
-23.7

Business Description

Industry: »
Compare: » details
Cadus Corporation was incorporated under the laws of the State of Delaware in January 1992 and until July 30, 1999 devoted all of its resources to the development and application of novel yeast-based and other drug discovery technologies. The Company has a wholly owned subsidiary, Cadus Technologies, Inc., which holds all patents, patent applications, know how, licenses and drug discovery technologies of the Company. The Company has developed technologies based on yeast that are useful in identifying drug discovery candidates targeted at G Protein-coupled receptors. Yeast is a single-celled microorganism that is commonly used to make bread, beer and wine. The Company has developed several proprietary drug discovery technologies that address many of the limitations of traditional drug discovery methods, including tools used to screen for compounds that act as agonists or antagonists to cell surface receptors and tools used to identify ligands to targeted orphan receptors. The Company developed a proprietary technology to insert human genes into yeast cells to create hybrid yeast cells. The Company's scientists typically created hybrid yeast cells by replacing yeast G Protein-coupled receptor genes and certain signaling molecules with their human equivalents. As a result, these hybrid yeast cells express a human G Protein-coupled receptor and a portion of its signaling pathway. The Company designed and developed more than twenty-five thousand genetically different yeast strains that could be used to build novel hybrid yeast cells. The Yeast System provides a facile means of identifying molecules that alter the activity of G protein coupled receptors through high throughput screening. The Yeast System also provides a procedure for identifying natural and artificial ligands for orphan G protein coupled receptors, i.e., proteins predicted to be GPCRs. The biotechnology and pharmaceutical industries are competitive. The Company main competitor is Glaxo Smith Kline, Plc, which might use yeast as a drug discovery medium.
» More Articles for KDUS

Headlines

Articles On GuruFocus.com
Deep Value Nano Cap + Reallocating Cash + Recent Convincing Insider Buys Oct 06 2014 
Carl Icahn Buys a Pharmaceutical-Turned-Real Estate Company Jun 10 2014 
Morning Coffee: Real-Time Picks Jun 10 2014 
Knowing When a Stock Is Cheap Enough to Buy Mar 21 2012 
comment on KDUS Mar 05 2012 
How Long Should You Hold a Net-Net? Feb 13 2012 
Cadus Corporation (OTC:KDUS) in the WSJ Jul 19 2010 

More From Other Websites
CADUS CORP Financials Aug 22 2014
CADUS CORP Files SEC form 10-Q, Quarterly Report Aug 14 2014
Cadus - Shell Company Turning Into Real Estate Venture Jun 18 2014
CADUS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 06 2014
Cadus Announces Completion of Rights Offering Jun 06 2014
CADUS CORP Files SEC form 10-Q, Quarterly Report May 14 2014
IPOs and Transactions: March 24 - 28 Mar 31 2014
CADUS CORP Files SEC form 10-K, Annual Report Mar 18 2014
CADUS CORP Files SEC form 8-K, Change in Directors or Principal Officers Mar 10 2014
CADUS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition... Feb 10 2014
CADUS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events Jan 22 2014
CADUS CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Dec 03 2013
Farpoint sends letter to Cadus Corp board memeber Brett Icahn Nov 20 2013
Icahn Versus Frost Nov 14 2013
Cadus Reports Third Quarter 2013 Results Nov 05 2013
CADUS CORP Files SEC form 10-Q, Quarterly Report Nov 05 2013
CADUS CORP Files SEC form 8-K, Other Events Sep 17 2013

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK